SAN DIEGO (AP) — SAN DIEGO (AP) — Oncternal Therapeutics, Inc. (ONCT) on Thursday reported a loss of $8.4 million in its first quarter.

On a per-share basis, the San Diego-based company said it had a loss of $2.83.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $2.88 per share.

The biopharmaceutical company posted revenue of $569,000 in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $176,000.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ONCT at https://www.zacks.com/ap/ONCT

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News